CV Sciences Inc

cvsciences.com

What Do They Do?

Sells hemp-derived supplements, CBD products, and plant-based foods to consumers through retailers and online channels, and supplies softgels and tinctures to supplement and nutrition companies.

How Do They Make Money?

Customers buy the company’s products, and payment is tied to shipment to them or delivery to a point they designate. It also makes softgels and tinctures for customers using their formulations or its own, with formulation help.

FY2025 revenue

Who Are Their Customers?

Consumers buy through the company’s websites and e-commerce platforms, while retailers, distributors, wholesalers, and e-tailers carry its products. Plant-based foods in Europe are generally sold to territory distributors; supplement and nutrition companies also buy manufacturing services.

Do Revenues Turn Into Profits?

No. It lost $958K in FY2025.

Operating income, FY2025

−3% of revenue

▼ −79% (Loss) vs FY2024 (−$2.2M, −14%)

Net income, FY2025

−7% of revenue

▼ −60% (Loss) vs FY2024 (−$2.4M, −15%)

Free cash flow, FY2025

−4% of revenue

▼ −42% (Loss) vs FY2024 (−$879K, −6%)

How Are They Changing?

Since the FY2025 annual report

Latest quarter: Q2 FY2026, the three months to Jun 30, 2026

Revenue: ▼ −18%; vs $3.6M in Q2 FY2025
Net income: ▲ +197% (Loss); vs −$261K in Q2 FY2025

Shrinking. Revenue fell 31% in 4 years, from $20M in FY2021 to $13.8M in FY2025, about 9% a year.

Plant-based foods The earlier report describes hemp extracts and herbal supplements; the latest report also includes plant-based foods sold under Cultured Foods and Lunar Fox.

Who Do They Compete With?

Competes with Charlotte's Web Holdings, cbdMD, Medterra CBD, GW Pharmaceuticals, Jazz Pharmaceuticals, and Harmony Biosciences Holdings

Comments